Author

Shougat Barua

Institutions: Harvard University, Dana-Farber Cancer Institute

Observed institutions: Harvard University, Dana-Farber Cancer Institute

ORCID: 0009-0003-7352-1173

Observed ORCID: 0009-0003-7352-1173

OpenAlex ID: A5113060533

Subunit-specific analysis of cohesin-mutant myeloid malignancies reveals distinct ontogeny and outcomes

2024 · Johann-Christoph Jann, Christopher B. Hergott, et al. · Leukemia · 17

Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients with Myelodysplastic Syndromes/Neoplasms (MDS): An Analysis from the International Consortium for MDS (icMDS) Validate Database

2024 · Benjamin Rolles, Jan Philipp Bewersdorf, et al. · Blood · 5

Subunit-Specific Analysis of Cohesin-Mutant Myeloid Malignancies Reveals Distinct Ontogeny and Outcomes

2023 · Johann-Christoph Jann, Christopher B. Hergott, et al. · Blood · 1

Impact of Response to Hypomethylating Agent‐Based Therapy on Survival Outcomes in the Context of Baseline Clinical‐Molecular Risk and Transplant Status in Patients With Higher‐Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS)

2026 · Benjamin Rolles, Jan Philipp Bewersdorf, et al. · American Journal of Hematology

Works count: 4

Citation count: 23

H-index: 2

I10-index: 1